Story perspectives

WHO Starts Ebola Drug Trial in Eastern Congo Amid Crisis

7/5/2026

Summary

Story summary

WHO launched a trial of remdesivir and MBP134 against the Bundibugyo Ebola strain in eastern Congo, coordinated by DRC’s Institut National de Recherche Biomédicale.
The trial enrolled a patient on July 2 at the Evangelical Medical Center in Bunia, with 1,400 cases and 438 deaths recorded.
Researchers will monitor participants for 28 days, expect up to 1,000 enrollments over months, and say mistrust, attacks on treatment centers and supplies hinder response.

1 of 1

Story summary

WHO launched a trial of remdesivir and MBP134 against the Bundibugyo Ebola strain in eastern Congo, coordinated by DRC’s Institut National de Recherche Biomédicale.
The trial enrolled a patient on July 2 at the Evangelical Medical Center in Bunia, with 1,400 cases and 438 deaths recorded.
Researchers will monitor participants for 28 days, expect up to 1,000 enrollments over months, and say mistrust, attacks on treatment centers and supplies hinder response.